Arrowhead Pharmaceuticals (ARWR) Non Operating Income (2010 - 2026)
Arrowhead Pharmaceuticals' Non Operating Income came in at -$8.81 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), compared with -$13.54 million a year earlier.
Powered by 
Analysis
Arrowhead Pharmaceuticals (ARWR) Non Operating Income (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Arrowhead Pharmaceuticals reported Non Operating Income of -$25.64 million; for FY2025 (ended Sep 30, 2025), it came in at -$46.81 million.
- Going back by fiscal year, Non Operating Income was -$11.38 million in FY2024, -$1.49 million in FY2023, $5.8 million in FY2022 (-29.2%) and $8.19 million in FY2021 (-4.9%).
- The five-year range for quarterly Non Operating Income is -$13.7 million (fiscal Q1 2025) to $3.7 million (fiscal Q2 2026).
- Business Quant data shows ARWR's Non Operating Income at $3.7 million (Q2 2026), -$12.54 million (Q1 2026) and -$7.99 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 269.00 Mn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | - |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | - |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | -73.00 Mn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 387.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | - |
| 10 | Arrowhead Pharmaceuticals | 8.36 Bn | 3.13 Bn | - | -8.81 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -8.81 Mn |
| Mar 31, 2026 | 3.70 Mn |
| Dec 31, 2025 | -12.54 Mn |
| Sep 30, 2025 | -7.99 Mn |
| Jun 30, 2025 | -13.54 Mn |
| Mar 31, 2025 | -11.59 Mn |
| Dec 31, 2024 | -13.70 Mn |
| Sep 30, 2024 | -10.60 Mn |
| Jun 30, 2024 | 2.16 Mn |
| Mar 31, 2024 | -805,000.00 |
| Dec 31, 2023 | -2.14 Mn |
| Sep 30, 2023 | -660,000.00 |
| Jun 30, 2023 | -680,000.00 |
| Mar 31, 2023 | -489,000.00 |
| Dec 31, 2022 | 340,000.00 |
| Sep 30, 2022 | 1.67 Mn |
| Jun 30, 2022 | 863,000.00 |
| Mar 31, 2022 | 2.81 Mn |
| Dec 31, 2021 | 449,000.00 |
| Sep 30, 2021 | 1.51 Mn |
API Access
Arrowhead Pharmaceuticals Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=ARWR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "ARWR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=ARWR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();